407 related articles for article (PubMed ID: 29206336)
1. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.
Patorno E; Gopalakrishnan C; Franklin JM; Brodovicz KG; Masso-Gonzalez E; Bartels DB; Liu J; Schneeweiss S
Diabetes Obes Metab; 2018 Apr; 20(4):974-984. PubMed ID: 29206336
[TBL] [Abstract][Full Text] [Related]
2. Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records.
Huybrechts KF; Gopalakrishnan C; Franklin JM; Zint K; Franca LR; Bartels DB; Landon J; Schneeweiss S
Clin Pharmacol Ther; 2019 Apr; 105(4):979-993. PubMed ID: 30341980
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.
Patorno E; Gopalakrishnan C; Brodovicz KG; Meyers A; Bartels DB; Liu J; Kulldorff M; Schneeweiss S
Diabetes Obes Metab; 2019 Aug; 21(8):1824-1836. PubMed ID: 30941884
[TBL] [Abstract][Full Text] [Related]
4. Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data.
Cesta CE; Hernández-Díaz S; Huybrechts KF; Bateman BT; Vine S; Seely EW; Patorno E
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1350-1359. PubMed ID: 37461243
[TBL] [Abstract][Full Text] [Related]
5. Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis.
Kong AM; Farahbakhshian S; Pendergraft T; Brouillette MA; Mukherjee B; Smith DM; Sheehan JJ
Curr Med Res Opin; 2017 Oct; 33(10):1869-1877. PubMed ID: 28613952
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data.
Teltsch DY; Fazeli Farsani S; Swain RS; Kaspers S; Huse S; Cristaldi C; Nordstrom BL; Brodovicz KG
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):234-243. PubMed ID: 30677205
[TBL] [Abstract][Full Text] [Related]
8. Agreement and validity of electronic health record prescribing data relative to pharmacy claims data: A validation study from a US electronic health record database.
Rowan CG; Flory J; Gerhard T; Cuddeback JK; Stempniewicz N; Lewis JD; Hennessy S
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):963-972. PubMed ID: 28608510
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin/linagliptin single-pill combination therapy for patients with type 2 diabetes mellitus.
Jain RK
Expert Opin Pharmacother; 2017 Apr; 18(6):545-549. PubMed ID: 28375658
[TBL] [Abstract][Full Text] [Related]
10. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
[TBL] [Abstract][Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
12. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study.
Kim YG; Yoon D; Park S; Han SJ; Kim DJ; Lee KW; Park RW; Kim HJ
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28899989
[TBL] [Abstract][Full Text] [Related]
14. Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011.
Bae JP; Lage MJ; Mo D; Nelson DR; Hoogwerf BJ
J Diabetes Complications; 2016 Mar; 30(2):212-20. PubMed ID: 26689451
[TBL] [Abstract][Full Text] [Related]
15. The relative benefits of claims and electronic health record data for predicting medication adherence trajectory.
Franklin JM; Gopalakrishnan C; Krumme AA; Singh K; Rogers JR; Kimura J; McKay C; McElwee NE; Choudhry NK
Am Heart J; 2018 Mar; 197():153-162. PubMed ID: 29447776
[TBL] [Abstract][Full Text] [Related]
16. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
17. Assessing occurrence of hypoglycemia and its severity from electronic health records of patients with type 2 diabetes mellitus.
Nunes AP; Yang J; Radican L; Engel SS; Kurtyka K; Tunceli K; Yu S; Iglay K; Doherty MC; Dore DD
Diabetes Res Clin Pract; 2016 Nov; 121():192-203. PubMed ID: 27744128
[TBL] [Abstract][Full Text] [Related]
18. Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: A cross-sectional, unselected, retrospective study.
Anderson AE; Kerr WT; Thames A; Li T; Xiao J; Cohen MS
J Biomed Inform; 2016 Apr; 60():162-8. PubMed ID: 26707455
[TBL] [Abstract][Full Text] [Related]
19. Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP).
Fujitani Y; Fujimoto S; Takahashi K; Satoh H; Hirose T; Hiyoshi T; Ai M; Okada Y; Gosho M; Mita T; Watada H
Diabetes Res Clin Pract; 2016 Nov; 121():146-156. PubMed ID: 27710821
[TBL] [Abstract][Full Text] [Related]
20. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record.
Brouwer ES; West SL; Kluckman M; Wallace D; Masica AL; Ewen E; Kudyakov R; Cheng D; Bowen J; Fleming NS
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):920-8. PubMed ID: 22250059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
